Alternative Blog Styles

You are currently browsing the Eye on the Cure blog archives for July, 2012.



Meet Dr. Steve Rose

Dr. Steve RoseSteve is highly respected for his expertise and tireless commitment to finding treatments and cures for vision-robbing retinal diseases.

Dr. Steve Rose 

Newsletter Sign Up

*  
*  
*  
*  


   Please leave this field empty

Archive for July, 2012

A retina with dry AMD. The yellow spots (called drusen) accumulate and can cause damage in AMD. The human body has highly impressive mechanisms to protect itself from harm. For example, a group of molecules known as the complement system work with antibodies to kill invading bacteria by punching holes in them and letting the internal contents leak out.
Read more

Lab BeakersWe, at Eye on the Cure, like to keep folks up-to-date on the latest retinal research developments, as soon as they’re vetted – meaning verified as legitimate – and/or come in. But we also appreciate when the mainstream media chimes in, especially when they cite the Foundation’s efforts and expertise.

Read more

Reinhard Rubow (left) and Miikka Terho.It was only a few days after what’s known as a “bionic retina” was implanted behind Miikka Terho’s left eye – the one that had completely lost vision 16 years previously – that he started to “see” again.

Read more

A transcorneal electrical stimulation device developed by Okuvision GmbHThis past weekend, I had the pleasure and the privilege of participating in the 17th International Congress of Retina International in Hamburg, Germany. Retina International is a volunteer association of 33 national groups for people with retinal degenerations.  The Congress is the European equivalent of the Foundation’s VISIONS conference. With research presentations translated into several languages, I felt like I was at the United Nations. I myself presented (in English) an update and review of many of the clinical trials underway for retinal degenerative diseases.
Read more

Implantable Miniature TelescopeThe ideal way to deal with a disease like age-related macular degeneration (AMD) is to prevent it from causing vision loss in the first place. For example, Dr. Barbel Rohrer is developing a Foundation-funded drug that slows retinal degeneration, and resulting vision loss, by bolstering the energy supply of cells in the retina.
Read more